Does cetuximab improve control of advanced head and neck cancer? A second look at the randomized trial by Bonner, et al.

被引：0
|
作者：
Mell, L. K. [1 ]
Dignam, J. J. [1 ]
Salama, J. K. [1 ]
Haraf, D. J. [1 ]
Vokes, E. E. [1 ]
Weichselbaum, R. R. [1 ]
机构：
[1] Univ Chicago Hosp, Chicago, IL 60637 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2007年 / 69卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2007.07.1562
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2387
引用
收藏
页码：S419 / S419
页数：1
相关论文
共 50 条
  • [1] Re: Haddad et al. Barriers to clinical trial recruitment in head and neck cancer
    Main, B. G.
    [J]. ORAL ONCOLOGY, 2015, 51 (05) : E22 - E22
  • [2] Second opinion reporting in head and neck pathology: perspective on Mullin et al.
    Edwards, Paul C.
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2015, 119 (06): : 599 - 600
  • [3] Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial
    Magrini, Stefano Maria
    Buglione, Michela
    Corvo, Renzo
    Pirtoli, Luigi
    Paiar, Fabiola
    Ponticelli, Pietro
    Petrucci, Alessia
    Bacigalupo, Almalina
    Crociani, Monica
    Lastrucci, Luciana
    Vecchio, Stefania
    Bonomo, Pierluigi
    Pasinetti, Nadia
    Triggiani, Luca
    Cavagnini, Roberta
    Costa, Loredana
    Tonoli, Sandro
    Maddalo, Marta
    Grisanti, Salvatore
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (05) : 427 - +
  • [4] Correction to Kasibhatla et al. How much radiation is the chemotherapy worth in advanced head and neck cancer?
    Fowler, Jack F.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (02): : 326 - 329
  • [5] Cetuximab and radiotherapy versus cisplatin and radiotherapy for locally-advanced head and neck cancer: a randomized phase II trial
    Vozy, A.
    Cuenca, X.
    [J]. ONCOLOGIE, 2016, 18 (06) : 429 - 430
  • [6] Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer
    Ferris, Robert L.
    Moskovitz, Jessica
    Kunning, Sheryl
    Ruffin, Ayana T.
    Reeder, Carly
    Ohr, James
    Gooding, William E.
    Kim, Seungwon
    Karlovits, Brian J.
    Vignali, Dario A. A.
    Duvvuri, Umamaheswar
    Johnson, Jonas T.
    Petro, Daniel
    Heron, Dwight E.
    Clump, David A.
    Bruno, Tullia C.
    Bauman, Julie E.
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (07) : 1335 - 1344
  • [7] Randomized trial of supplemental β-carotene to prevent second head and neck cancer
    Mayne, ST
    Cartmel, B
    Baum, M
    Shor-Posner, G
    Fallon, BG
    Briskin, K
    Bean, J
    Zheng, TZ
    Cooper, D
    Friedman, C
    Goodwin, WJ
    [J]. CANCER RESEARCH, 2001, 61 (04) : 1457 - 1463
  • [8] In response to Ham et al.: Antibiotics effect on outcome in head and neck cancer
    Nerina, Denaro
    Carlo, Merlano Marco
    [J]. EUROPEAN JOURNAL OF CANCER, 2019, 117 : 119 - 120
  • [9] Chemoradiotherapy for advanced head and neck cancer - Analysis of a prospective, randomized trial
    Mitra D.
    Basu S.
    Deb A.R.
    Rashid M.A.
    Sur P.K.
    [J]. Indian Journal of Otolaryngology and Head and Neck Surgery, 2006, 58 (4): : 360 - 363
  • [10] RANDOMIZED ADJUVANT CHEMOTHERAPY TRIAL IN ADVANCED HEAD AND NECK-CANCER
    STOLWIJK, C
    VANDENBROEK, P
    WAGENER, DJT
    LEVENDAG, PC
    KAZEM, I
    [J]. CLINICAL OTOLARYNGOLOGY, 1983, 8 (04): : 285 - 285
12345